News | Artificial Intelligence | August 08, 2019

Half of Hospital Decision Makers Plan to Invest in AI by 2021

Survey shows hospitals realize AI’s market value, seeking to drive efficiency and reduce costs

Half of Hospital Decision Makers Plan to Invest in AI by 2021

August 8, 2019 — A recent study conducted by Olive AI explores how hospital leaders are responding to the imperative to drive efficiency and reduce costs through strategic investments in non-clinical technologies. The study audits the state of adoption and investment in artificial intelligence (AI) and robotic process automation (RPA).

The cost of healthcare is increasing, due in part to breakthroughs in patient care, including advancements in medical treatments and clinical technologies. However, the digitization of healthcare and the complexities of reimbursement are fundamentally changing the way hospital data is managed, adding new layers of administrative processes. The result: increasing operational expenses across hospitals and health systems.

The Olive AI survey found that: 

We are Still in the Early Stages of AI Adoption in Healthcare

  • Only 50 percent of hospital leaders interviewed said they were familiar with the concept of AI/RPA;
  • More than half of hospital leaders were unable to name an AI/RPA vendor or solution;
  • Twenty-three percent of hospital leaders are looking to invest in AI/RPA today, while half plan to do so by 2021; and
  • Those familiar with AI/RPA are two times as likely to implement AI to solve workflow challenges instead of leveraging existing systems

With an estimated $1 trillion of healthcare spending going toward administrative costs (labor being the largest component), hospital leaders are starting to look expansively at technology that improves efficiency across the enterprise.

Familiarity and Understanding of AI Impacts Decision-Making

  • Purchasing approaches vary. Forty-three percent of hospital leaders preferred to choose a company to build, deliver, monitor and support automations, 26 percent preferred to choose the platform themselves, then hire consultants to build their solution, 18 percent preferred to choose the platform themselves and have their employees build the solution, and 13 percent preferred to hire consultants to both choose the platform and build the solution;
  • Meanwhile, improving efficiency and reducing costs remains a top three priority (behind improving quality of care and improving patient satisfaction/engagement); and
  • Executives see high growth potential in automating high-volume, repetitive tasks in these functions: supply chain management, revenue cycle management, finance and human resources 

“As an industry, healthcare is united by a mission to deliver better patient care, and a huge barrier to delivering that promise is the challenge that 1 in every 3 dollars is spent on administrative expenses. Imagine what could be done if more resources were available to focus on patient care,” said Rebecca Hellmann, chief marketing officer of Olive. “With AI becoming more mainstream and offering a clearer path to value, hospitals no longer need to build out a massive technological infrastructure before benefiting from the efficiencies that it can create.”

Olive conducted this survey in partnership with Sage Growth Partners, an independent healthcare market research, consulting and marketing firm. The survey respondents included 115 executives spanning the roles of chief financial officers, chief information officers, revenue cycle managers and supply chain functional leaders at hospital systems and independent hospitals in the United States.

For more information: www.oliveai.com

Related Content

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

News | Artificial Intelligence | May 26, 2020
May 26, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.

A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.

News | Artificial Intelligence | May 19, 2020
May 19, 2020 — Artificial inte...
TeraRecon will accelerate innovation in its advanced visualization and AI platforms for image-related decision support to clinical specialists

TeraRecon's End-to-End AI Ecosystem

News | Artificial Intelligence | March 04, 2020
March 4, 2020 — SymphonyAI Group, an operating group of lea
The FDA granted marketing authorization of the Caption Guidance software to Caption Health Inc. in February 2020. It uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.

GE Healthcare partnered with the AI developer Dia to provide an artificial intelligence algorithm to auto contour and calculate cardiac ejection fraction (EF). The app is now available on the GE Vscan pocket, point-of-care ultrasound (POCUS) system, as seen here displayed at RSNA 2019. Watch a VIDEO demo from RSNA.

Feature | Artificial Intelligence | February 11, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
A new technology for detecting low glucose levels via electrocardiogram (ECG) using a non-invasive wearable sensor, which with the latest artificial intelligence (AI) can detect hypoglycemic events from raw ECG signals has been made by researchers from the University of Warwick.

A new technology for detecting low glucose levels via electrocardiogram (ECG) using a non-invasive wearable sensor, which with the latest artificial intelligence (AI) can detect hypoglycemic events from raw ECG signals has been made by researchers from the University of Warwick.

 

News | Artificial Intelligence | January 13, 2020
A new technology for detecting low glucose levels via electrocardiogram (ECG) using a non-invasive wearable sensor,...
Videos | Artificial Intelligence | November 07, 2019
Piotr Slomka explains how his team at Cedars-Sinai is working on intelligent patient risk prediction algorithms...
AI Could Use EKG Data to Measure Patient's Overall Health Status

Image courtesy of iStock

News | Artificial Intelligence | August 29, 2019
In the near future, doctors may be able to apply artificial intelligence (AI) to electrocardiogram data in order to...